80 likes | 209 Views
Feature Set. ARG2. gene/disease. X. Feature 2. Dedifferentiation of adenoid cystic carcinoma : report of a case implicating p53 gene mutation. ARG1. ARG2. X. Y. gene/disease. Feature 3.
E N D
ARG2 gene/disease X Feature 2 • Dedifferentiation of adenoid cystic carcinoma: report of a case implicatingp53 gene mutation.
ARG1 ARG2 X Y gene/disease Feature 3 • (negative example) We have assessed the role of CYP1A1 genotype in lung cancer risk in the Chinese population via a case-control study.
ARG1 ARG2 X gene/disease Y Feature 4 • The ACE-D allele had additive and dominant effects with regard to the occurrence of significant ventricular arrhythmias after adjusting for other risk factors. • RESULTS: Only the three medulloblastomas with T antigen expression also showed nuclear positivity with antibodies to p53.
Feature 5 • These results suggested that targeted disruption of Cyp19causedanovulation and precocious depletion of ovarian follicles. • Furthermore, AML cells with methylated p15(INAK4B) tended to express higher levels of DNMT1 and 3B. ARG1 ARG2 disease/gene gene/disease X
Feature 7 ARG1 MOD ARG1 • Mutations in the EYA1 gene (localised to 8q13.3) account for nearly 70% of BOR syndrome cases exhibiting at least three of the major features. • We have shown previously that adenoviral-mediated E2F-1 over expression induces efficient apoptosis incolonadenocarcinoma cells. gene/disease X Y disease/gene
Results • results for the test set